Literature DB >> 9769280

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

T Hajiro1, K Nishimura, M Tsukino, A Ikeda, H Koyama, T Izumi.   

Abstract

When dyspnea must be assessed clinically, there are three methods of assessment: the measurement of dyspnea with activities of daily living using clinical dyspnea ratings such as the modified Medical Research Council (MRC), the Baseline Dyspnea Index (BDI), and the Oxygen Cost Diagram (OCD); the measurement of dyspnea during exercise using the Borg scale; to assess the influence of dyspnea on health-related quality of life (HRQoL) using disease-specific questionnaires such as the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ). The purpose of the present cross-sectional study was to clarify relationships between dyspnea ratings and HRQoL questionnaires by applying factor analysis. One hundred sixty-one patients with mild to severe COPD completed pulmonary function tests, progressive cycle ergometer testing for exercise capacity, assessment of dyspnea, HRQoL, anxiety, and depression. Factor analysis demonstrated that the MRC, BDI, OCD, and Activity of the SGRQ, and Dyspnea of the CRQ, were grouped into the same factor, and the frequency distribution histograms of these five measures showed virtually the same distribution. The Borg scale at the end of maximum exercise was found to be a different factor. The MRC, BDI, OCD, and Activity in the SGRQ, and Dyspnea in the CRQ demonstrated the same pattern of correlation with physiologic data, and they had significant relationships with FEV1 (correlation coefficients [Rs] = 0.31 to 0. 48) and maximal oxygen uptake (Rs = 0.46 to 0.60). Disease-specific HRQoL questionnaires, the SGRQ and the CRQ, which contain a specific dimension for evaluating dyspnea, may be substituted for clinical dyspnea ratings in a cross-sectional assessment. Dyspnea rating at the end of exercise may provide further information regarding dyspnea.

Entities:  

Mesh:

Year:  1998        PMID: 9769280     DOI: 10.1164/ajrccm.158.4.9802091

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  70 in total

1.  Influence of anxiety on health outcomes in COPD.

Authors:  Mark D Eisner; Paul D Blanc; Edward H Yelin; Patricia P Katz; Gabriela Sanchez; Carlos Iribarren; Theodore A Omachi
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

Review 2.  Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; M Rutten-Van Mölken; J Buffels; O Van Schayck; P-A Gevenois; R Pellegrino; E Derom; W De Backer
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

3.  Development of disability in chronic obstructive pulmonary disease: beyond lung function.

Authors:  Mark D Eisner; Carlos Iribarren; Paul D Blanc; Edward H Yelin; Lynn Ackerson; Nancy Byl; Theodore A Omachi; Stephen Sidney; Patricia P Katz
Journal:  Thorax       Date:  2010-11-03       Impact factor: 9.139

4.  Determinants of gait speed in COPD.

Authors:  Craig Karpman; Zachary S DePew; Nathan K LeBrasseur; Paul J Novotny; Roberto P Benzo
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

5.  Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.

Authors:  Yohana De Jesús-Berrios; Ruth A Santos-Rodríguez; Donald Dexter; Mariely Nieves-Plaza; Cruz M Nazario
Journal:  P R Health Sci J       Date:  2015-03       Impact factor: 0.705

6.  Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.

Authors:  Thomas Keller; Laura J Spece; Lucas M Donovan; Edmunds Udris; Scott S Coggeshall; Matthew Griffith; Alexander D Bryant; Richard Casaburi; J Allen Cooper; Gerard J Criner; Philip T Diaz; Anne L Fuhlbrigge; Steven E Gay; Richard E Kanner; Fernando J Martinez; Ralph J Panos; David Shade; Alice Sternberg; Thomas Stibolt; James K Stoller; James Tonascia; Robert Wise; Roger D Yusen; David H Au; Laura C Feemster
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

7.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

8.  Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation.

Authors:  Michael H Cho; George R Washko; Thomas J Hoffmann; Gerard J Criner; Eric A Hoffman; Fernando J Martinez; Nan Laird; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2010-03-16

9.  Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study.

Authors:  Akane Haruna; Toru Oga; Shigeo Muro; Tadashi Ohara; Susumu Sato; Satoshi Marumo; Daisuke Kinose; Kunihiko Terada; Michiyoshi Nishioka; Emiko Ogawa; Yuma Hoshino; Toyohiro Hirai; Kazuo Chin; Michiaki Mishima
Journal:  BMC Pulm Med       Date:  2010-03-07       Impact factor: 3.317

10.  Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease.

Authors:  S K Chhabra; A K Gupta; M Z Khuma
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.